During the past decade, Clinical Research Center for Rare Diseases conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center for Rare Diseases" #1 collaborator was "Istituto Superiore di Sanità" with 2 trials as a collaborator and "Bio3 Research s.r.l. - Milan Italy" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Center for Rare Diseases" are "Type 2 Diabetes" (4 trials), "Renal Transplant" (2 trials), "Alport Syndrome" (1 trials), "Autosomal Dominant Polycystic Kidney Disease (ADPKD)" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Clinical Research Center for Rare Diseases" in a lesser frequency.

Most popular intervention types in "Clinical Research Center for Rare Diseases" are "Drug" (11 trials), "Other" (4 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACE I, ATA II and Statins" (1 trials), "Ad libitum health diet" (1 trials), "Benazepril, Valsartan and Fluvastatin" (1 trials), "Biochemical analyses." (1 trials) and "Caloric restriction" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Center for Rare Diseases" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Center for Rare Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clinical Research Center for Rare Diseases, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Center for Rare Diseases, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".